|
|
||||||||
J Thorac Cardiovasc Surg 2009;137:556-559
© 2009 The American Association for Thoracic Surgery
Congenital Heart Disease |
a Pediatric Cardiovascular Centre, Qingdao Children's Hospital, Qingdao, China
b Shanghai Co Ltd of Xingzhuangjiyi Alloy Material, Shanghai, China
Received for publication December 10, 2007; revisions received February 24, 2008; accepted for publication May 9, 2008. * Address for reprints: Pan Silin, MS, Pediatric Cardiovascular Center, Qingdao Children's Hospital, Qingdao, Shandong 266011, China. (Email: silinpan{at}126.com).
Objective: We sought to summarize the preliminary clinical experience of minimally invasive transthoracic device closure of perimembranous ventricular septal defects with a new delivery system without cardiopulmonary bypass.
Methods: Twenty-one patients aged 11 months to 12 years (median age, 3.6 years) with isolated perimembranous ventricular septal defects underwent minimally invasive device closure with an inferior sternotomy of 3 to 5 cm under transesophageal echocardiographic guidance. A single per–right ventricular U-like suture was established, and a new delivery system was introduced, aided by a 16-gauge trocar, including a guidewire, proper sheath, and loading sheath. The proper size of devices was determined by means of transesophageal echocardiographic analysis, and then the device was released under real-time transesophageal echocardiographic monitoring if no significant aortic regurgitation, abnormal atrioventricular valvular motion, or residual interventricular shunt appeared.
Results: All of the defects were successfully closed. No residual shunt, noticeable aortic or tricuspid regurgitation, or significant arrhythmias appeared during more than 5 months of follow-up.
Conclusion: Minimally invasive transthoracic device closure of perimembranous ventricular septal defects with a new delivery system without cardiopulmonary bypass is feasible and safe under transesophageal echocardiographic guidance. However, it is necessary to evaluate the intermediate and long-term results.
This article has been cited by other articles:
![]() |
G.-C. Zhang, Q. Chen, L.-W. Chen, H. Cao, L.-P. Yang, X.-J. Wu, X.-F. Dai, and D.-Z. Chen Transthoracic echocardiographic guidance of minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: initial experience Eur Heart J Cardiovasc Imaging, February 8, 2012; (2012) jes028v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xing, Q. Wu, S. Pan, Y. Ren, and H. Wan Transthoracic device closure of ventricular septal defects without cardiopulmonary bypass: experience in infants weighting less than 8 kg Eur J Cardiothorac Surg, September 1, 2011; 40(3): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tao, K. Lin, Y. Shi, H. Song, R. C. Lui, C. Gan, and Q. An Perventricular device closure of perimembranous ventricular septal defects in 61 young children: Early and midterm follow-up results J. Thorac. Cardiovasc. Surg., October 1, 2010; 140(4): 864 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, L.-W. Chen, Q.-M. Wang, H. Cao, G.-C. Zhang, and D.-Z. Chen Intraoperative Device Closure of Doubly Committed Subarterial Ventricular Septal Defects: Initial Experience Ann. Thorac. Surg., September 1, 2010; 90(3): 869 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xing, S. Pan, Q. An, Z. Zhang, J. Li, F. Li, Q. Wu, and Z. Zhuang Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: Multicenter experience and mid-term follow-up J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1409 - 1415. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |